Taiwan Liposome Company, Ltd. American Depository Shares
TLC
TLC was delisted on the 28th of September, 2021.
7 hedge funds and large institutions have $3.5M invested in Taiwan Liposome Company, Ltd. American Depository Shares in 2019 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 7 → 7 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
2% less capital invested
Capital invested by funds: $3.58M → $3.5M (-$79K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$2.11K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$12.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
KPC
1
Karst Peak Capital
Hong Kong
| $2.96M | – | – | – |
|
|
2
Millennium Management
New York
| $474K | -$12.4K | -2,400 | -3% |
|
3
Creative Planning
Overland Park,
Kansas
| $52K | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $9K | +$2.11K | +408 | +32% |
|
|
AG
5
Advisor Group
Phoenix,
Arizona
| $3K | – | – | – |
|
|
HR
6
Howe & Rusling
Rochester,
New York
| $3K | – | – | – |
|
7
Morgan Stanley
New York
| $1K | – | – | – |
|
TLC Hedge Fund Activity: Q3 2019 in Review
7 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Taiwan Liposome Company, Ltd. American Depository Shares (TLC) for Q3 2019, worth a combined $3.5M — down 2.2% from $3.58M a quarter earlier.
Fund positioning in TLC was balanced in Q3 2019: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, adding an estimated $2.11K. The largest seller was Millennium Management, cutting an estimated $12.4K.
- 7 institutional investors held Taiwan Liposome Company, Ltd. American Depository Shares (TLC) as of Q3 2019, unchanged from Q2 2019.
- Funds reported $3.5M of Taiwan Liposome Company, Ltd. American Depository Shares stock for Q3 2019, down 2.2% quarter-over-quarter.
- 0 funds opened new Taiwan Liposome Company, Ltd. American Depository Shares positions in Q3 2019 and 0 closed out.
- The largest Taiwan Liposome Company, Ltd. American Depository Shares buyer in Q3 2019 was UBS Group, an estimated $2.11K added.
- The largest Taiwan Liposome Company, Ltd. American Depository Shares seller in Q3 2019 was Millennium Management, an estimated $12.4K sold.
Based on aggregated 13F filings for Q3 2019.